Table 3.
Resistant phenotype | Induction test phenotype | ERY susceptibility | CLI susceptibility | No. of patients with diabetes | Total no. of isolates | % |
---|---|---|---|---|---|---|
iMLSB | D test positive | R | S | 118 | 180 | 22.5 |
MS | D test negative | R | S | 82 | 130 | 16.25 |
cMLSB | R | R | R | 176 | 220 | 27.5 |
No resistance | S | S | S | 124 | 270 | 33.75 |
CLI = clindamycin; cMLSB = constitutive macrolide–lincosamide–streptomycin group B; D test = disk approximation test; ERY = erythromycin; iMLSB = inducible macrolide–lincosamide–streptomycin group B; MS = methicillin sensitive; R = resistant; S = sensitive.